Groupama Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1M | Buy |
61,297
+9,364
| +18% | +$4.13M | 0.45% | 48 |
|
|
2025
Q1 | $25.6M | Buy |
51,933
+8,454
| +19% | +$4.17M | 0.51% | 48 |
|
|
2024
Q4 | $17.4M | Buy |
43,479
+9,149
| +27% | +$3.65M | 0.35% | 60 |
|
|
2024
Q3 | $12.8M | Buy |
34,330
+3,739
| +12% | +$1.4M | 0.33% | 62 |
|
|
2024
Q2 | $14.3M | Buy |
30,591
+20,033
| +190% | +$9.39M | 0.19% | 77 |
|
|
2024
Q1 | $12.2M | Sell |
10,558
-14,481
| -58% | -$16.8M | 0.22% | 83 |
|
|
2023
Q4 | $10.2M | Buy |
+25,039
| New | +$10.2M | 0.27% | 71 |
|